Zhuhai Trinomab Pharmaceutical Co., Ltd.

This study tested whether an injection called TNM001 could safely prevent serious lower respiratory tract infections caused by RSV in babies under one year old. Over 2,200 infants in China were randomly given either the injection or a placebo and followed for about 8 months. The …

This study tested a new antibody injection called TNM002 to see if it could help prevent tetanus, a serious bacterial infection. Researchers compared it to the standard protective shot (human tetanus immunoglobulin) and a placebo in 240 healthy Chinese adults. The main goal was t…

This study tested whether a new antibody injection called TNM001 could prevent serious lung infections caused by Respiratory Syncytial Virus (RSV) in high-risk infants. About 315 infants under 1 year old entering their first RSV season received either the antibody or a placebo sh…